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Abstract 
Background: Gold nanoparticles (AuNPs) are a popular choice for use in medical and biomedical research applica‑
tions. With suitable functionalisation AuNPs can be applied in drug delivery systems, or can aid in disease diagnosis. 
One such functionalisation is with chitosan, which enables efficient interaction and permeation of cellular mem‑
branes, providing an effective adjuvant. As both AuNPs and chitosan have been shown to have low toxicity and high 
biocompatibility their proposed use in nanomedicine, either individually or combined, is expanding. However, further 
toxicological and immunological assessments of AuNP‑chitosan conjugates are still needed. Therefore, we have evalu‑
ated how AuNP functionalisation with chitosan can affect uptake, cytotoxicity, and immunological responses within 
mononuclear cells, and influence the interaction of AuNPs with biomolecules within a complex biofluid. The AuNPs 
used were negatively charged through citrate‑coating, or presented either low or high positive charge through chi‑
tosan‑functionalisation. Uptake by THP‑1 cells was assessed via transmission electron microscopy and electron energy 
loss spectroscopy, pro‑inflammatory responses by ELISA and qRT‑PCR, and cell death and viability via lactate dehydro‑
genase release and mitochondrial activity, respectively. Interactions of AuNPs with protein components of a fre‑
quently used in vitro cell culture medium supplement, foetal calf serum, were investigated using mass spectrometry.
Results: Although cells internalised all AuNPs, uptake rates and specific routes of intracellular trafficking were 
dependent upon chitosan‑functionalisation. Accordingly, an enhanced immune response was found to be chitosan‑
functionalisation‑dependent, in the form of CCL2, IL‑1β, TNF‑α and IL‑6 secretion, and expression of IL‑1β and NLRP3 
mRNA. A corresponding increase in cytotoxicity was found in response to chitosan‑coated AuNPs. Furthermore, 
chitosan‑functionalisation was shown to induce an increase in unique proteins associating with these highly charged 
AuNPs.
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Background
Due to quantum size effects, and an increase in stability 
compared to other metal nanoparticles (NPs) [1], gold 
NPs (AuNPs) are one of the most promising materials 
utilised in nanotechnology. Amongst other areas, the 
extensive application of AuNPs in medicine and bio-
medical research is fast becoming a promising avenue 
of nanotechnology [2]. Aided by easy functionalisation 
[1] applications range from diagnostic imaging [3, 4] to 
the improved efficacy of drug and gene delivery systems 
[5–8], or the development of a novel “bedside tool” for 
cancer diagnosis [9] where functionalised AuNPs can 
recognise specific patterns of volatile organic compounds 
found in the breath of non-small-cell lung cancer patients 
[9, 10]. Other applications of AuNPs in nanomedicine 
involve functionalisation with chitosan, a molecule which 
itself has also been a focus of many medical applications 
[11]. Chitosan is a polysaccharide derivative of chitin, 
sourced from the seafood industry, which in recent years 
has been incorporated into medical research and practice 
due to low toxicity, high biocompatibility and its ability to 
interact and permeate cellular membranes, providing an 
effective adjuvant [12]. This topic is the focus of an exten-
sive review series edited by Amidi and Hennink [13]. In 
respect to nanomedicine, chitosan has been proposed for 
use in gene therapy [14, 15], such as in siRNA [16], DNA 
[17, 18], and drug delivery systems [19, 20], and in cancer 
therapy [21, 22]. Conjugates of chitosan and AuNPs have 
been presented as a suitable tool for biosensing [23, 24], 
in drug delivery [25, 26], as antibacterial [27] and antifun-
gal agents [28], and for tumour targeting [29]. Due to the 
relatively high level of deacetylation compared to chitin, 
chitosan is considered as hydrophilic [30]; in many appli-
cations it is this form which is used [23–27]. However, the 
development of nanomedicines utilising chitosan has also 
further processed this polymer to generate hydrophobic 
or amphiphilic particles [31]. While treatment efficacy is 
maintained [32], or even enhanced [33], blood circulation 
time may be extended with these novel materials [32], an 
enhanced cellular uptake efficiency [31, 34] and a wider 
intracellular distribution can be obtained, as well as the 
potential to avoid the unwanted degradation of the deliv-
ered package can be achieved through encouragement of 
alternative uptake mechanisms, such as macropinocy-
tosis [31]. As AuNPs and chitosan are often considered 
inert and biocompatible, the proposed use of both agents 
in nanomedicine is expanding. For example, Au-chitosan 
NPs almost identical to those used in the present study 
are being recommended for enhanced insulin delivery via 
oral and nasal administration [26]. Furthermore, with an 
FDA classification of “generally regarded as safe” (GRAS), 
chitosan has been approved as a food additive and in 
wound dressing [35]. However, the resultant high local-
ised concentrations possible during administration, war-
rants that these materials are considered more closely.
The available literature mostly corroborates the bio-
compatibility of AuNPs. For example, 3–8  nm lysine-
capped AuNPs were shown to induce no detrimental 
effects in mouse macrophages in  vitro [36]. Using air 
liquid interface (ALI) exposure, 15  nm citrate-coated 
AuNPs were found to induce no immune responses or 
anomalous redox activities in numerous cell types [37]. 
In both these studies AuNPs were internalised by cells. 
Furthermore, 3.7  nm pegylated AuNPs (therefore nega-
tively charged) were even observed within the nucleus of 
HeLa cells with no apparent cytotoxicity [38]. However, 
other studies, discussed below, report conflicting results 
and the biocompatibility of AuNPs could not always be 
confirmed. It is at present not fully clear which aspects of 
Au-based NPs could be responsible for changing biologi-
cally inert NPs into potentially toxic NPs.
The current literature highlights various character-
istics which may result in enhanced toxicity of AuNPs. 
Particularly small (<2  nm) Au-phenylphosphine NPs 
were found to be considerably more cytotoxic than 
larger (15  nm) AuNPs in numerous cell types [39]. An 
increase in cytotoxicity has been attributed to the pres-
ence of positive charges on the NP surfaces [40, 41]. In 
the study by Schaeublin et al. [40] both anionic and cati-
onic NPs induced reactive oxygen species (ROS)-asso-
ciated cytotoxicity. However, the increased cell death 
elicited by positively charged AuNPs was concomitant 
with a disruption of mitochondrial membrane poten-
tial and stimulation of intracellular calcium signalling 
[40]. Furthermore, chitosan-gold nanocomposites which 
have been developed for bactericidal applications were 
shown to considerably reduce the viability of mammalian 
cells [27]; this toxic effect was found to be dependent on 
numerous factors, and effects could be placated when 
using chitosan of differing molecular weight and degree 
Conclusions: It can be concluded that functionalisation of AuNPs with the perceived non‑toxic biocompatible 
molecule chitosan at a high density can elicit functionalisation‑dependent intracellular trafficking mechanisms and 
provoke strong pro‑inflammatory conditions, and that a high affinity of these NP‑conjugates for biomolecules may be 
implicit in these cellular responses.
Keywords: Charged gold nanoparticles, Chitosan, Exocytosis, Pro‑inflammatory responses, Protein corona
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of deacetylation, or by altering the original synthesis 
formulation, in terms of Au stock concentration [27]. A 
positive particle surface charge has often been linked to 
an increase in cellular uptake and concomitant increase 
in toxic potential of AuNPs [41]. Primary reticuloen-
dothelial cells internalise greater quantities of positively 
charged AuNPs than negatively charged ones [42]. This 
is understandable as anionic particles display a limited 
or non-existent interaction with cell membranes, while 
an increase in cationic AuNPs’ toxicity can be mediated 
by an increase in interaction between cationic AuNPs 
and the negatively charged lipid bilayer [43]. To further 
complicate the assessment of biological responses to NP 
characteristics, the initial interaction of NPs with protein 
components of biofluids can alter cellular responses and 
NP characteristics [44–47].
In the present study we investigate the interaction of 
differently charged AuNPs with proteins in cell culture 
medium (CCM) and the biological consequences of this 
in mononuclear phagocytes, including uptake, cytotox-
icity and inflammatory responses. We have therefore 
assessed (1) AuNP functionalisation-dependent inter-
nalisation by a human monocytic cell line (THP-1), (2) 
AuNP-induced cell death and inflammatory responses 
within the same cell line, and (3) the impact of chitosan-
AuNP conjugates on interactions with foetal calf serum 
(FCS) components of standard in  vitro CCM. Citrate-
coated AuNPs of ~10 nm in diameter were used as syn-
thesised or conjugated with different concentrations of 
chitosan, of particularly high deacetylation of 75–85 %, to 
give a range of surface charges (both negative and posi-
tive). The THP-1 cell line was chosen as it is a frequently 
used and versatile model both for monocytes and mac-
rophages, which are two immune cell types with high 
phagocytic potential that are expected to take up and 
respond to NPs in many contexts.
Results
Nanoparticles
AuNPs were ~10  nm in diameter. These included one 
negatively charged sample (Au_SC, −45 mV ± 0.2), with 
the surface charge provided by the loose attachment of 
citrate ions. The remaining two samples (Au_CHIT-L 
and Au_CHIT-H) had increasing levels of positive charge 
(23  mV  ±  1.0, 65  mV  ±  1.0, respectively) provided by 
increasing concentrations of chitosan surface densities 
of 0.001, and 0.1 wt % (in solution). The intrinsic particle 
characteristics, upon synthesis, are provided in Table 1.
Uptake and intracellular trafficking of AuNPs by THP‑1 cells
The human monocytic cell line THP-1 was used to assess 
the uptake of functionalised AuNPs. Transmission elec-
tron microscopy (TEM) micrographs of 30 min and 6 h 
incubation of cells with AuNPs are shown in Figs. 1 and 
2, respectively. After only 30 min both positively charged 
AuNPs were observed by TEM to be internalised. Small 
agglomerates could be seen within vesicles and not within 
the cytoplasm or other cell compartments. No observa-
tions of intracellular Au_SC could be made during this 
short exposure period. After 6  h exposure THP-1 cells 
were seen to have internalised all AuNPs types. All were 
observed within vesicles in different states of agglomera-
tion, with Au_CHIT-H observed as larger agglomerates. 
In some cells, Au_CHIT-H were shown to be held within 
larger vesicles, and were also observed around the exte-
rior of the cells. It can be seen in Fig.  2e, f that smaller 
NP-containing vesicles combined close to the cell surface, 
forming larger vesicles. As the extracellular NPs shown in 
Fig. 2f appeared to be accompanied with biological mate-
rial, it was thought feasible that this fusion of lysosomes 
may ultimately have led to exocytosis of internalised 
AuNPs. At this time point, TEM micrograph examina-
tion of a cell which had released AuNP material revealed 
that the cell appeared to maintain a healthy condition 
(data not shown), indicating this to be an active pro-
cess. The intracellular electron dense material observed 
in these TEM micrographs was confirmed to be Au by 
Energy Electron Loss Spectroscopy (EELS) (Additional 
file 1A–F), while similar electron dense material outside 
of the cell was not Au in all cases (Additional file 1E, F). 
The most likely explanation for these objects is that they 
are osmium, a contamination derived from the fixation 
Table 1 Nanoparticle properties
Sample ID, functionalisation, surface charge, size, pH in solvent, concentration of stock, and suspension solvent
a The acid or basic pH values turn to physiologically pH (around 7–8) when diluted at 1:10 (v/v) in cell culture medium
b SC sodium citrate
c 1 % = 1 g chitosan (chit.)/100 ml of solution
Sample Surface coating Z‑potential (mV) Size nm pHa Concentration (mg/ml) Solvent
Gold nanoparticles (AuNPs)
 Au_SC SCb −45 ± 0.2 10 ± 1.5 7 0.032 Sodium citrate 2.2 mM
 Au_CHIT‑L 0.001 % Chit. +23 ± 1.0 7 ± 3 5 0.025 Chitosan 0.001 %c
 Au_CHIT‑H 0.1 % Chit. +65 ± 1.0 7 ± 3 5 0.025 Chitosan 0.1 %
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process. However, electron dense material which was 
shown to be actively exocytosed by cells was confirmed 
as AuNPs (Additional file  1G, H). Within the electron 
energy loss (eV) spectra used for Au detection, there was 
also the appearance of phosphorus in most traces (Addi-
tional file 1B, D, F, H), which is to be expected due to the 
relatively high level of phosphorus within mammalian 
cells [48]; an observation corroborated by a disappear-
ance of this peak in measurements taken extracellularly 
(Additional file 1E, F, green (control) trace).
Increased cytotoxicity associated with chitosan‑coating 
of AuNPs
THP-1 cells were primed with phorbol 12-myristate 
13-acetate (PMA) prior to treatment with functional-
ised AuNPs. To determine cell death and viability, THP-1 
cells were assessed for membrane integrity in the form of 
lactate dehydrogenase (LDH) release, and for mitochon-
drial activity using the CTB assay. Cells were exposed 
to Au_SC in a concentration range of 0.8–3.2 and 0.6–
2.5 µg/ml for both Au_CHIT NPs, for 4 and 24 h (Fig. 3). 
Viability was unaffected by Au_SC, while a low but sig-
nificant release of LDH was shown after 48  h exposure 
of the highest concentration of Au_SC. The cytotoxicity 
in response to Au_CHIT-L and Au_CHIT-H was more 
pronounced. A significant reduction in cell viability and 
release of LDH was both time- and dose-dependent in 
response to these two AuNPs. These responses were con-
siderable and far greater than those to Au_SC. As there 
was an abrupt increase in cytotoxicity in response to 
Au_CHIT-L, lower concentrations were further assessed 
(Additional file  2). Solvent controls (sodium citrate and 
chitosan) at concentrations in accordance with particle 
exposures were also assessed for their influence of cell 
Fig. 1 TEM micrographs of AuNP endocytosis by THP‑1 cells. Images show 30 min incubation with a medium only, b Au_SC, c Au_CHIT‑L, d 
Au_CHIT‑H; AuNPs compartmentalised within endocytotic vesicles identified by black arrows; with nucleus, mitochondria and extracellular space 
identified by N, M and X, respectively
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Fig. 2 TEM micrographs of AuNP endocytosis and intracellular trafficking by THP‑1 cells. Images show 6 h incubation with a medium only, b 
Au_SC, c Au_CHIT‑L, d Au_CHIT‑H; and Au_CHIT‑H‑containing vesicles shown fusing at the cell surface and eventual exocytosis (e, f); AuNPs com‑
partmentalised within endocytotic vesicles identified by black arrows; with nucleus, mitochondria and extracellular space identified by N, M and X, 
respectively
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death and reduced viability, and were found to induce 
neither (Additional file 3).
Inflammation and inflammasome activation correlate 
with chitosan‑coating of AuNPs
THP-1 cells were used to assess the induction of a pro-
inflammatory environment. Initially, the response of 
THP-1 cells to AuNPs under different cell activation 
states was investigated using Au_CHIT-H only. Cells 
were treated with Au_CHIT-H for 4 and 24 h in the pres-
ence or absence of lipopolysaccharide (LPS), and with or 
without PMA pre-stimulation. The resulting supernatant 
was analysed for secretion of IL-1β. Without PMA pre-
stimulation (Additional file 4A, B) IL-1β was significantly 
induced at both time points when LPS co-stimulation 
was used. Without LPS co-stimulation IL-1β secretion 
was found only at the longer exposure period of 24 h. The 
4  h exposure of Au_CHIT-H in the absence of LPS co-
stimulation induced a 2.6-fold increase in IL-1β secretion 
compared to control cells, however, this was not found 
to be statistically significant (p  =  0.072). When PMA 
pre-stimulation was used (Additional file  4C, D), IL-1β 
secretion was observed at both time points when LPS 
was included, but was found only after 4 h when LPS was 
absent. At 24 h, in the absence of LPS, Au_CHIT-H did 
induce a 4.5-fold increase in IL-1β secretion compared 
to medium only control cells. Again, this was not found 
to be significant (p = 0.086). Each experimental protocol 
used here demonstrated the pro-inflammatory response 
which developed upon exposure of AuNPs coated with 
chitosan. Due to the increased sensitivity for IL-1β secre-
tion of PMA-primed cells with additional LPS co-stimu-
lation, it was decided to use this system to further study 
Au_CHIT NP-induced inflammation.
PMA-stimulated THP-1 cells were exposed to all func-
tionalised AuNPs in a concentration range of 0.2–3.2 µg/
ml for Au_SC and 0.2–2.5 µg/ml for both Au_CHIT, for 4 
and 24 h, with LPS co-stimulation of 1 ng/ml. The result-
ing supernatants were assessed for CCL2, IL-1β, TNF-α 
and IL-6. No significant release of CCL2 was found after 
4 h particle exposures (Fig. 4a), while after 24 h (Fig. 4e) 
a significant CCL2 secretion was shown with treatments 
of 1.25 and 2.5 µg/ml Au_CHIT-H. This effect was shown 
to be even higher than for the 100  ng/ml LPS positive 
control. None of the other AuNPs used induced CCL2 
secretion. Release of TNF-α was found to dose-depend-
ently increase in response to both Au_CHIT NPs during 
4 (Fig. 4b) and 24 h (Fig. 4f ), an effect not seen in Au_SC 
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Fig. 3 AuNPs induced cytotoxicity in THP‑1 cells. Viability (mitochondrial activity) (a–c) and cytotoxicity (LDH release) (d–f) in PMA‑stimulated cells, 
after treatment with Au_SC (a, d), Au_CHIT‑L (b, e), and Au_CHIT‑H (c, f), for 4, 24 and 48 h; 1 ng/ml LPS was used for co‑stimulation, Triton X‑100 
was used as positive control. Results are expressed as, for viability,  % viability compared to 100 % control cells, and as the ratio change compared to 
controls for LDH release, and each data point represents the mean ± SEM of three independent biological replicates; statistical significance (deter‑
mined by ANOVA with Tukey posthoc) is shown by +p < 0.05 for 4 h exposures, ^p < 0.05 for 24 h, and *p < 0.05 for 48 h, compared to relevant 
controls
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exposures. A similar dose dependency in treatments of 
Au_CHIT NPs was observed in secretion of IL-6 after 4 h 
(Fig. 4c), which was no longer evident after 24 h exposure 
(Fig. 4g). Au_SC did not stimulate significant IL-6 release. 
A dose-dependent increase in IL-1β was observed 
with exposure of both chitosan-coated AuNPs after 
4 h (Fig. 4d), and to all AuNPs after 24 h (Fig. 4h). Dur-
ing these exposure periods Au_CHIT-L and Au_CHIT-
H were shown to be particularly proficient in inducing 
IL-1β secretion. Inflammatory responses of THP-1 cells 
were also assessed in response to relevant concentrations 
of the AuNP solvents (sodium citrate and chitosan solu-
tions) and no significant responses were observed (Addi-
tional file 5).
With respect to the high IL-1β secretion, further exper-
iments were performed to assess what impact differ-
ently charged AuNPs have on specific stages of the IL-1β 
secretory pathway. These included the expression of IL-
1β and NLRP3 mRNA, and determination of inflamma-
some activation. PMA-primed THP-1 cells were exposed 
to Au_SC at 3.2 µg/ml and both Au_CHIT at 2.5 µg/ml in 
the presence and absence of 1 ng/ml LPS (for co-stimu-
lation). For gene expression 1 and 24 h time points were 
used, while 4 and 24  h were used for determination of 
inflammasome activation. For determination of NLRP3 
inflammasome involvement these exposures were also 
performed in the presence and absence of the caspase-1 
inhibitor Ac-YVAD-CMK.
In the absence of LPS co-stimulation IL-1β mRNA 
was found to be elevated in response to Au_CHIT-L and 
Au_CHIT-H at both times measured (Fig.  5a). All IL-
1β mRNA levels were shown to be significantly greater 
than controls (medium only treated cells) except the 1 h 
exposure of Au_CHIT-H. With the inclusion of LPS co-
stimulation, IL-1β gene expression was significantly ele-
vated (compared to LPS-treated control cells) in response 
to all AuNPs after 1 h, and only to Au_CHIT NPs after 
24  h. The IL-1β gene expression observed after 24  h in 
response to Au_CHIT-L and Au_CHIT-H, with and with-
out LPS co-stimulation, was notably higher than with 
Au_SC treatments. NLRP3 mRNA (Fig.  5b) was signifi-
cantly increased only in response to Au_CHIT-L during 
the 1 h incubation period, and only towards Au_CHIT-H 
during the 24 h exposure period.
In the absence of LPS co-stimulation the level of 
secreted IL-1β protein increased in response to Au_
CHIT-H after 4 h (Fig. 5c-I) and to both Au_CHIT NPs 
after 24 h (Fig. 5c-II). These responses were significantly 
reduced when cells were pre-treated with Ac-YVAD-
CMK. In the case of 24  h Au_CHIT-H exposure, IL-1β 
was still significantly elevated when compared to relevant 
control (Ac-YVAD-CMK-treated cells). Under the same 
conditions, Ac-YVAD-CMK pre-treatment induced sig-
nificantly lower levels of TNF-α upon stimulation with 
Au_SC and Au_CHIT-H for 4 h, albeit within these expo-
sures TNF-α secretion was not found to be significantly 
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Fig. 4 AuNPs induced pro‑inflammatory response of THP‑1 cells. Secretion of CCL2 (a, e), TNF‑α (b, f), IL‑6 (c, g) and IL‑1ß (d, h) from PMA‑stimu‑
lated cells, in response to Au_SC, Au_CHIT‑L, and Au_CHIT‑H; 1 ng/ml LPS was used for co‑stimulation; with 1 and 100 ng/ml LPS for controls; results 
are expressed as cytokine release in pg/ml, and each data point represents the mean ± SEM of three independent biological replicates; statistical 
significance (determined by ANOVA with Tukey posthoc) is shown by *p < 0.05, compared to relevant controls (1 ng/ml LPS); or by Spearman’s rank 
correlation coefficient to assess the NP dose dependent relationship with cytokine release, where Ζ = p < 0.05
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higher than for control cells in response to any NPs 
(Fig. 5c-III). After 24 h Au_CHIT-H induced significant 
TNF-α secretion, regardless of Ac-YVAD-CMK inclusion 
(Fig. 5c-VI). With the inclusion of 1 ng/ml LPS co-stim-
ulation, all AuNPs induced significant IL-1β release at 
both time points tested (Fig. 5d-I and -II). IL-1β release 
was found to be particularly prominent in response to 
both Au_CHIT-L and Au_CHIT-H at each time point. 
Ac-YVAD-CMK pre-treatment was shown to reduce 
IL-1β secretion in response to all AuNPs and at both time 
points. TNF-α was significantly increased in response to 
both Au_CHIT NPs after 4 h, with no Ac-YVAD-CMK-
dependent effects observed (Fig.  5d-III). With 24  h 
exposure the high response elicited by Au_CHIT-L and 
Au_CHIT-H was maintained, and although Ac-YVAD-
CMK was shown to lower these responses, no significant 
decrease was observed (Fig.  5d-IV). Au_SC induced no 
TNF-α secretion.
Chitosan surface density influences AuNP interactions 
with cell culture medium proteins
AuNPs were incubated in the presence of 10, 55 or 100 % 
FCS for 24  h and subsequently washed and isolated via 
centrifugation. The number and identity of proteins asso-
ciated with NPs can be viewed in Additional files 6, 7 and 
8. Further classification of proteins was according to their 
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biological function, isoelectric point (pI), molecular weight 
(MW), hydropathicity (GRAVY) and aliphatic index 
(Fig. 6). The proteins presented in Fig. 6, and in Additional 
files 6, 7 and 8 are the unique proteins which appeared in 
every biological replicate, as this was considered a good 
quality control, and infers that these are the proteins which 
would routinely interact with these AuNPs. However, in 
addition to this, the unique proteins which were found 
associated with AuNP-protein complexes not only in all 
biological replicates, but also in all FCS concentrations, are 
presented in Additional files 9 and 10.
An increase in the number of unique proteins associ-
ating with AuNPs was found to be mainly dependent on 
AuNP functionalisation with a particularly high con-
centration of chitosan (Fig.  6). There was little difference 
observed between Au_SC and Au_CHIT-L. However, 
when the concentration of chitosan on the NP surface 
increased in Au_CHIT-H, so did the number of unique 
proteins. Au_SC were found to accumulate slightly more 
proteins than Au_CHIT-L, except when NPs were incu-
bated in 100 % FCS, in which case a strict charge depend-
ency was observed. Protein functional categories were 
assigned as: lipoproteins, proteins associated with trans-
port, acute phase responses, complement, coagulation, or 
other plasma proteins. Using this classification the increase 
in proteins associating with Au_CHIT-H was determined 
to be an increase in proteins of all functional groups. Par-
ticularly striking were increases in other plasma proteins, 
and proteins associated with complement, coagulation 
and acute phase responses. These additional FCS proteins 
were not only shown to be functionally different, they were 
also found to be characteristically different. Out of the 
four protein parameters evaluated (pI, MW, GRAVY and 
aliphatic index), the hydropathicity of proteins associating 
with AuNPs remained similar. However, a greater range of 
protein pI, MW and, to a smaller extent, aliphatic index 
was observed in the proteins which associated with AuNPs 
of particularly high chitosan density.
Discussion
The focus of this study was to determine how AuNP 
functionalisation can (I) influence uptake and (II) inflam-
matory responses in mononuclear phagocytic cells, and 
(III) alter the interaction of proteins with these NP con-
jugates. Negatively charged citrate-stabilised AuNPs were 
compared to AuNPs containing different surface densi-
ties of positively charged chitosan.
AuNP endocytosis and intracellular trafficking by THP‑1 
cells is dependent on AuNP functionalisation
Internalisation of NPs has been shown to be depend-
ent on size [36, 49–51], aggregation state [52], surface 
charge (and/or functionalisation) [41, 53, 54], or simply 
on cell phenotype [41, 50, 52]. Here we have shown that 
rapid internalisation of AuNPs by THP-1 cells was driven 
by chitosan coating of AuNPs. While positively charged 
AuNPs already internalised within 30  min, negatively 
charged AuNPs were only evident inside cells after 6  h. 
This is in line with much of the literature concerning 
charged NPs, as cationic AuNPs have been shown to 
keenly associate with negatively charged lipid bilayers 
[43], to be internalised rapidly [55], and to enter cells via 
alternative mechanisms compared to anionic NPs [56]. 
Rapid endocytosis of cationic AuNPs has been reported 
to occur within 30 min [57], and even as early as 5 min 
[58], while in both these cases endocytosis of anionic 
AuNPs was not evident at the respective time points. It 
should be noted that it is possible that these differences 
were due to the poor colloidal stability, and therefore 
aggregation and rapid sedimentation of cationic NPs 
[59]. However, a more likely explanation is the increased 
affinity of cationic NPs for the negatively charged cell 
membrane [57], an occurrence also postulated by Hühn 
et al. [41] in the exposure of fibroblasts with both nega-
tively and positively charged AuNPs.
Besides uptake rates, AuNP surface charge has been 
shown to influence intracellular trafficking. We have 
shown that with eventual endocytosis of all NP charge 
states, NP agglomerates were held within endocytic vesi-
cles. Similar observations have been made elsewhere, 
including internalisation of lysine-capped AuNPs by 
macrophages [36]. However, in the study by Shukla et al. 
[36], intracellular trafficking resulted in a perinuclear 
arrangement of AuNP agglomerates. Furthermore, Ojea-
Jiménez et  al. [57] also observed endosomes contain-
ing cationic AuNPs migrating towards the nucleus, and 
additionally, rupturing of the endosomes in proximity 
of nuclei, leaving AuNPs available to enter the nucleus. 
The explanation given for this behaviour was the pro-
ton sponge hypothesis [57], a mechanism which was 
also shown to occur in monocyte-derived macrophages 
exposed to cationic amino-functionalised PSNPs 
(45.1 mV), and not in response to anionic PSNPs [60]. It 
is considered that cationic NPs present within a lysosome 
undergoing acidification may accumulate protons enter-
ing via the proton pump, therefore acting as a “proton 
sponge” and maintaining the pump active, resulting in 
osmotic swelling, lysis and release of the lysosome con-
tent into the cytoplasm [44]. We did not observe AuNPs 
free within the cytoplasm, and therefore it is unlikely that 
our cationic AuNPs induced a “proton sponge” effect, 
neither did they accumulate near the cells’ nucleus. 
Instead the vesicles containing highly positively charged 
Au_CHIT-H, and this type of NP alone, were found to 
accumulate near and fuse with the outer cell membrane. 
The fusion of lysosomes with the plasma membrane and 
Page 10 of 20Boyles et al. J Nanobiotechnol  (2015) 13:84 
SC CHIT-L CHIT-H
0
15
30
45
SC CHIT-L CHIT-H
0
15
30
45
SC CHIT-L CHIT-H
0
15
30
45
SC CHIT-L CHIT-H
4
5
6
7
8
9
SC CHIT-L CHIT-H
4
5
6
7
8
9
SC CHIT-L CHIT-H
4
5
6
7
8
9
SC CHIT-L CHIT-H
0
100
200
300
SC CHIT-L CHIT-H
0
100
200
300
SC CHIT-L CHIT-H
0
100
200
300
-2
-1
0
1
SC            CHIT-L         CHIT-H
-2
-1
0
1
SC            CHIT-L         CHIT-H
-2
-1
0
1
SC            CHIT-L         CHIT-H
SC CHIT-L CHIT-H
0
50
100
150
SC CHIT-L CHIT-H
0
50
100
150
SC CHIT-L CHIT-H
0
50
100
150
# 
id
en
tif
ie
d
pr
ot
ei
ns
A
lip
ha
tic
in
de
x
H
yd
ro
pa
th
ic
ity
M
W
 (k
D
)
Is
oe
le
ct
ric
po
in
t (
pI
)
SCF%001SCF%01 55% FCS
Fig. 6 Characteristics of FCS proteins associating with AuNPs. The number of unique proteins identified, via LTQ‑Orbitrap mass spectrometry, in 
AuNP‑FCS complexes were characterised by their functional groupings, isoelectric point, molecular weight, hydropathicity and aliphatic index; 
evaluated when incubated in (left column) 10 %, (centre column) 55 %, and (right column) 100 % FCS; data presented is of unique proteins identified 
in all 3 biological replicates; protein functional classification is based on http://www.Uniprot.org, protein parameters were determined using the 
ProtParam tool of http://www.expasy.org; this analysis was performed with three technical replicates of each biological replicate; for confidence of 
identification the proteins presented in these graphs are only proteins found in every biological replicate
Page 11 of 20Boyles et al. J Nanobiotechnol  (2015) 13:84 
subsequent exocytosis of ingested material is a recog-
nised pathway [61], and involves membrane repair dur-
ing the procedure [62], therefore it may not necessarily 
elicit further cell stress or death, but is often reported in 
conjunction with intracellular calcium signalling [62, 63], 
a signalling event known to be involved in NP-induced 
pro-inflammatory responses [64–66]. With this in mind, 
and as we observed cells undergoing this process to be 
in good health, it seems feasible that the extracellular 
AuNPs identified, and associated with biological mate-
rial, may have been exocytosed by cells. If so, our obser-
vations imply that this specific mechanism of exocytosis 
was dependent on NP surface charge, a conclusion which 
was also made by Oh et  al. [67], who observed a simi-
lar response of cells to positively charged AuNPs. NPs 
would exit the cell in large agglomerates combined with 
intracellular material. A noteworthy point is that while 
Oh et al. [67] demonstrated exocytosis within 48 h using 
positively charged AuNPs with a zeta potential closer to 
Au_CHIT-L, we have shown a potential route for exocy-
tosis within a far shorter exposure time to AuNPs with 
a far greater zeta potential. This implies that the level of 
NP charge which is presented may play an important role 
in exocytosis. As many intracellular applications of NPs 
such as drug delivery systems rely upon vesicle transport 
routes, the implications of this observed exocytosis are 
important to consider, as the intrinsic toxicity of a mate-
rial for the whole organism may increase. These expul-
sions would include lysosome material, which itself could 
trigger unwanted biological effects, and NP material 
which could lead to further cell interactions and second-
ary endocytosis. It should be noted that although we, and 
Oh et al. [67], propose NP charge as a controlling factor 
for AuNP exocytosis, other studies have also implicated 
NP size in determining exocytosis [51].
Inflammation and cytotoxicity driven by AuNP 
functionalisation
Macrophages are among the principal immune effec-
tor cells, therefore responses of this cell type are consid-
ered paramount in determining biological responses to 
medically relevant NPs. Here we have demonstrated that 
within our phagocytic models, AuNP functionalisation 
with chitosan plays a crucial role in mediating AuNP-
induced cell death and cellular inflammatory responses, 
which were well aligned with the uptake patterns previ-
ously discussed. The initial phagocyte model used in 
this study was that of the THP-1 monocytic cell line, in 
which we identified a rapid uptake of AuNPs dependent 
upon the functionalisation with chitosan. As one goal 
of this study was to assess inflammasome activation in 
response to functionalised AuNPs it was thought prudent 
to assess IL-1β secretion within different activation states 
of our phagocyte model, as the differential regulation of 
this protein is considered to differ between monocytes 
and macrophages [68]. This was restricted to a combina-
tion of PMA-priming and LPS co-stimulation, as this is 
a method commonly used in studies involving NLRP3 
inflammasome activation in THP-1 cells [68–70]. We 
observed the highest release and greatest sensitivity for 
IL-1β secretion when cells were both PMA-primed and 
co-stimulated with LPS, and therefore this condition was 
used in subsequent experiments. As we did not further 
assess the internalisation of AuNPs after these activa-
tion steps were included, we can only postulate as to how 
uptake would have been affected. Subtle differences in 
NP uptake have been reported within phagocytes, with 
primary macrophages internalising greater quantities of 
anionic polystyrene NPs (PSNPs) than THP-1 cells; while 
the reverse was true for cationic PSNPs, as THP-1 cells 
were shown to endocytose greater quantities than pri-
mary macrophages. These differences were driven by the 
use of different mechanisms of uptake; phagocytosis was 
employed by macrophages, while uptake by undifferen-
tiated THP-1 cells was driven by dynamin II-dependent 
endocytosis, or by macropinocytosis in PMA-differenti-
ated THP-1 cells [53]. This may imply that the differences 
in pro-inflammatory cytokine release in response to dif-
ferent cell activation procedures may be influenced by 
uptake mechanisms in place of actual quantity of inter-
nalised AuNPs. However, using AuNPs of particularly 
high positive surface charge Bartneck et al. [71] observed 
uptake within macrophages to be considerably greater 
than in monocytes. It is, therefore, feasible that in our 
case the enhanced activation state of the PMA-primed 
THP-1 cells resulted in a higher pro-inflammatory medi-
ator release due to distinct mechanisms employed result-
ing in an enhanced level of AuNP uptake.
A change of negative to positive charge on silica NPs 
(SiNPs) corresponded with an increase in cell death 
and oxidative stress in macrophages [72]; an outcome 
also observed by Hühn et  al. [41] in the treatment of 
HUVECs and C17.2 cells with charged AuNPs. In con-
trast, upon exposure of human keratinocytes, AuNPs 
were shown to induce cell death irrespective of whether 
the NPs held a positive, negative or neutral charge [40]. 
However, the extent of cell death was greater when NPs 
were charged, as was the mechanism of cytotoxicity [40]. 
It must be noted that the study by Schaeublin et al. [40] 
used concentrations of NPs far greater than those used 
here. Our results are in line with these studies, as we 
have shown that a switch from negative to positive sur-
face charge can induce significantly greater cell death 
in THP-1 cells. Moreover, using Au-chitosan compos-
ites formed of chitosan of a similar molecular weight to 
the one used in our study, Regiel-Futyra et al. [27] have 
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previously shown a reduction of cell viability in epithe-
lial cells (A549) comparable to that found here in phago-
cytic cells (THP-1). However, the concentrations used 
by Regiel-Futyra et  al. were far higher than those used 
here and their NP size was larger than those used in the 
present study. Regiel-Futyra et al. found no toxic effects 
when the NP concentration was lowered. This provides 
an indication of cell-specific sensitivities and/or NP size-
dependent responses. Notably, Regiel-Futyra et  al. were 
able to mollify these responses through using chitosan 
of different molecular weights. As their nanocomposites 
were found to possess considerable bactericidal activ-
ity, these results highlight an important step in modern 
development of nanotherapeutics, where subtle changes 
in formulation can dramatically ameliorate the effect 
upon mammalian cells while maintaining their functional 
purpose. The responses of THP-1 cells we observed at far 
lower NP concentrations compared to those identified in 
A549 cells by Regiel-Futyra et  al. could be explained by 
cell-specificity in terms of NP uptake, which raises the 
question of appropriate cell type choice when assessing 
medically relevant NMs. Hühn et  al. [41] demonstrated 
that while uptake of negatively charged AuNPs was 
unchanged across different cell phenotypes, the inter-
nalisation of positively charged ones was significantly dif-
ferent dependent on cell type; an observation also found 
elsewhere [50, 52, 73]. This can be attributed to the use of 
different uptake mechanisms employed [50], even when 
considering monocytes against macrophages [53]. In 
terms of NP uptake in THP-1 versus A549, it is difficult 
to elucidate any conformity within the literature. THP-1 
cells have been shown to accumulate a greater quantity of 
SiO2NPs than A549 cells, and at a faster rate [74]. How-
ever, the NP uptake which was quantified by Mohamed 
et  al. [74] was based on anionic NPs. A549 cells have 
been shown to readily internalise chitosan-coated AuNPs 
[75], and as non-phagocytic cells are considered to have 
a preference for cationic NPs compared to anionic ones 
[76], uptake of chitosan coated NPs by A549 could be 
potentially greater. Moreover, epithelial cells have been 
shown to internalise greater quantities of cationic NPs 
than macrophages [77]. In this study by Xia et  al. [77], 
uptake induced significant cell death in both cell types. 
However, the mechanisms were found to be different and 
dependent on surface charge. With apoptosis induced in 
macrophages through lysosomal rupture, and necrosis 
induced in epithelial cells upon internalisation through 
caveolae-dependent mechanisms [77]. Furthermore, in 
a study by Hsiao et al. [78] comparative NP uptake rates 
between A549 and THP-1 cells alternate dependent on 
NP size and exposure dose. It is therefore difficult cat-
egorically assign why we have observed this difference 
in sensitivity between our THP-1 responses and those of 
the A549 cells used by Regiel-Futyra et  al. however, we 
place the most likely explanation upon mechanisms of 
internalisation.
In a study by Arvizo et  al. [58] the proliferation and 
viability of human bronchial epithelial cells and human 
airway smooth muscle cells dosed with positively 
charged 10  nm AuNPs was found to be considerably 
hampered through the induction of apoptosis, with cor-
responding fluctuations in intracellular calcium signal-
ling. These events were not found in exposure of neutral 
or negatively charged AuNPs [58]. Changes in intra-
cellular calcium levels such as this would imply that 
positively charged AuNPs have the potential to stimu-
late greater inflammatory responses than negatively 
charged NPs. Here, we have shown that the secretion 
of the pro-inflammatory cytokine IL-1β was consider-
able in response to Au_CHIT NPs, which also induced 
high levels of IL-1β gene expression. These data led us 
to examine the involvement of the NALP3 inflamma-
some in charged AuNP-induced inflammatory responses. 
This mechanism is stipulated by many studies concern-
ing particle-induced inflammatory responses, including 
investigations into carbon nanotubes, amorphous silica, 
nano-TiO2 and asbestos [79–82]. The direct involvement 
of Au_CHIT-L and Au_CHIT-H in NALP3 inflamma-
some activation was confirmed here through the signifi-
cant reduction of AuNP-induced IL-1β secretion with the 
caspase-1 inhibitor Ac-YVAD-CMK, and the enhanced 
expression of NLRP3 mRNA. Other pro-inflammatory 
markers assessed were CCL2, TNF-α and IL-6. TNF-α 
and IL-6 were secreted in response to both Au_CHIT 
NPs, while CCL2 only in response to Au_CHIT-H. None 
of these pro-inflammatory markers were induced by Au_
SC. These data suggest that cellular pro-inflammatory 
responses were driven by NP surface charge, a finding 
corroborated elsewhere. IL-1β secretion by monocyte-
derived macrophages was shown by Lunov et al. [60] to 
be dependent on a positive surface charge, and pegylated 
Au nanorods (PEG-AuNRs) with a RGD peptide motif 
addition were shown to induce an increase in TNF-α and 
MIG in primary macrophages when compared to PEG-
AuNRs lacking this motif [42]. However, in the described 
studies, the amino-functionalised PSNPs were not able to 
induce TNF-α [60], the RGD motif was not able to induce 
IL-6 or IL-1β, and no charge dependency was shown for 
CCL2 secretion [42]. We observed a charge-dependent 
upregulation of all these factors, which would suggest 
that our observed pro-inflammatory responses were not 
only driven by charge, but also specifically by chitosan. 
This speculation was further strengthened by considering 
responses observed by Shukla et al. [36], who found nei-
ther TNF-α nor IL-1β in response to positively charged 
lysine-capped AuNPs in mouse macrophages. Shukla 
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et  al. [36] used AuNPs of a similar size to ours, and in 
higher concentrations. However, it is difficult to attrib-
ute these pro-inflammatory responses to the addition of 
chitosan alone as not only did control experiments show 
a lack of pro-inflammatory responses towards exposure 
of our NP solvents, but chitosan oligomers at a concen-
tration comparable to that found in these NP exposures 
actually reduce pro-inflammatory responses [83]. It is 
more likely that a factor contributing to the high cytokine 
release shown here is the rapid endocytosis of Au_CHIT-
L and Au_CHIT-H, and the perceived exocytosis of 
Au_CHIT-H. It is feasible that there was secondary inter-
nalisation of the exocytosed Au_CHIT-H, an event which 
has previously been demonstrated for 30  nm negatively 
charged peptide-functionalised AuNPs [84].
Effect of AuNP functionalisation on biomolecule 
interactions
Interactions between NPs and biofluid components occur 
immediately and ultimately result in a stable corona sur-
rounding the NP [47, 85, 86].This corona has been identi-
fied, in place of the particle itself, to play a major role in 
cellular responses, including cell attachment, inflamma-
tion, ROS generation, and cell death [45, 47, 85–87]. In 
fact, an interaction of cationic NPs with serum proteins 
has been shown to enhance cell binding, while reduced 
cell interactions were shown when NPs were anionic, 
inducing different mechanisms of uptake [56]. Therefore, 
it was considered that the difference in cellular response 
to the different functionalised AuNPs used in this study 
may, in part, be governed by the interactions occurring 
between these AuNPs and components of the CCM. We 
have focussed on protein components of FCS, as this is 
a supplement of CCM in the majority of in vitro studies. 
Furthermore, it allowed a comparative study of AuNP 
charge/functionalisation-related interactions with pro-
teins within a complex mixture, which represents a cen-
tral consideration as the formation of the protein corona 
determines the fate of NPs and strongly depends on the 
initial NP surface characteristics.
Although negatively charged NPs experience electro-
static repulsion with the majority of serum proteins, we 
found that Au_SC were still able to attract numerous 
proteins. This is reported to be likely due to the highly 
electrolytic media screening of these negative charges 
through the efficient decoration of both NP and protein 
surfaces with Ca2+ ions [88], allowing their close inter-
action, and subsequent reorientation and reorganization 
encouraging permanent interactions [89]. Our highly 
positively charged AuNPs were shown to accumulate 
a far greater number of proteins as their surface charge 
increased. Again this is understandable as cationic NPs 
attract proteins rapidly and with poor selectivity, thus 
leading to an increasing number of unique proteins, 
hindering effective reorganization and impeding corona 
hardening [89]. Nevertheless, due to most serum proteins 
being anionic, a stronger and faster association between 
the cationic AuNPs when compared to the anionic can 
be expected [57]. All AuNP charge states used here were 
shown to accumulate a common subset of FCS proteins 
including serum albumin, serotransferrin, alpha-1-acid 
glycoprotein, alpha-1-antiproteinase, alpha-1B-glycopro-
tein, alpha-2-HS-glycoprotein, hemoglobin fetal subu-
nit beta, vitamin D-binding protein, apolipoprotein A-I, 
apolipoprotein A-II and fetuin-B. However, as the AuNP 
charge was altered from negative to increasingly positive, 
an increased number of unique proteins associated with 
the AuNP-protein complexes was identified. More spe-
cifically, these additional unique proteins were identified 
as proteins associated with complement, coagulation and 
acute phase responses, as well as other plasma proteins. 
Furthermore, these proteins were also shown, in part, to 
differ in pI and MW compared to the common subset. 
The data presented here on protein attachment to AuNPs 
highlight the number of different/unique proteins associ-
ating with NPs; other studies have quantified total protein 
amounts. Using a well-defined adsorption study into the 
attachment of serum albumin to the surface of negatively 
and positively AuNPs, Hühn et al. [41] have shown that 
a corona formed of this protein is unaffected by surface 
charge, in terms of protein number and affinity. However, 
this phenomenon may not apply to all NP coatings, as 
citrate-coated NPs have been shown to generate particu-
larly strong binding with serum albumin [90]. Hence, it is 
possible that this is the reason for the lower abundance 
of proteins, other than albumin, found in our Au_SC-
associated protein complexes. Alternatively, the lower 
binding efficiency of the citrate-coated NPs used here 
may be due to an intrinsic charge dependency of AuNPs 
within a complex protein mixture. While Hühn et al. [41] 
investigated interactions of AuNPs with albumin alone, it 
was shown by Deng et al. [86] that within a complex pro-
tein solution an increase in bound protein was concomi-
tant with a switch from negatively to positively charged 
AuNPs. Further similarities between the data presented 
here and those of Deng et al. [86] were apparent. With an 
increasing density of positively charged functional group, 
chitosan in our study and poly[N-(2-aminoethyl)acryla-
mide] for Deng et al. [86], an increase in the number of 
bound proteins was observed. Furthermore, Deng et  al. 
[86], as did we, found that a far lower number of unique 
proteins would associate with citrate-coated AuNPs 
compared to NPs with other coatings. Tenzer et al. [91] 
have shown that negatively charged SiNPs predominately 
bind negatively charged blood plasma proteins. Here the 
negatively charged Au_SC were also shown to exclusively 
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bind negatively charged proteins (with pI  <  7). Protein-
NP complexes formed of highly positively charged 
Au_CHIT-H, although predominately associating with 
proteins of pI  <  7, were also found in conjunction with 
proteins of pI  >  7, indicating the attachment of posi-
tively charged proteins. This signifies that protein pI is in 
some way associated with attachment to highly charged 
AuNP-protein complexes, while other characteristics are 
less important than this macromolecular electrostatic 
interplay.
Within AuNP-protein complexes formed of Au_CHIT-
H we identified various molecules associated with 
cellular interaction and internalisation, including hyalu-
ronan-binding proteins such as anti-thrombin III, inter-
α-trypsin inhibitor heavy chains, and complement, which 
have already been implicated as mediators of AuNP-cell 
interactions [87]; fibrinogen, which has been implicated 
in specific NP-cell interactions and subsequent immune 
responses [86, 92]; and transferrin, which has often 
been associated with NP internalisation, with transfer-
rin-dependent clathrin-mediated endocytosis being a 
method employed within drug delivery systems [93]. This 
mechanism has previously been highlighted with expo-
sure of various mammalian cells to AuNPs [51], and with 
the intrinsic exocytotic recycling of the transferrin recep-
tor [93] may provide an interesting avenue for AuNP 
intracellular trafficking mechanisms. However, transfer-
rin was found bound to all AuNPs used here, although 
quantities have not been determined and may vary 
between different preparations. In summary it is evident 
that the highly positively charged NPs used in the pre-
sent study interact with many proteins within FCS which 
may contribute to the observed biological responses and 
unique intracellular trafficking.
Conclusions
We have shown that differently functionalised AuNPs 
evolve both extracellularly and inside the cell, which con-
sequently affects their biological impact. Here, the effect 
of the NP surface charge and charge intensity, through 
chitosan functionalisation, has been observed to radically 
affect the interactions with proteins, the intracellular fate 
of AuNPs, and consequently the cellular responses. We 
have consistently shown that the interaction with, and 
the toxicity induced in, cells of the mononuclear phago-
cyte system was driven by AuNP functionalisation with 
chitosan, and that increasing chitosan density can exac-
erbate these events; with enhanced uptake, enhanced cel-
lular responses, and furthermore, a potential rapid and 
unique exocytosis. Moreover, we have demonstrated that 
AuNP functionalisation with chitosan, a molecule per-
ceived as non-toxic and biocompatible, encourages a high 
affinity of AuNPs for biomolecules, which in turn led to 
cellular toxicity induced by two seemingly non-toxic NP-
conjugate components. Therefore, it would be unwise 
to still consider all AuNPs, of any size, shape or surface 
composition, as completely inert drug carriers. Final for-
mulations as a whole have to be assessed, since high den-
sity functionalisation with otherwise inert components 
may elicit potentially detrimental biological responses.
Methods
Materials
RPMI 1640, l-glutamine, streptomycin, penicillin, glutar-
aldehyde, lipopolysaccharide (LPS), Phorbol 12-myristate 
13-acetate (PMA), Tris(2-Carboxyethyl)phosphine 
hydrochloride solution (TCEP), iodoacetamide (IAA), 
Bradford reagent, BSA, acetonitrile (ACN) trifluoroacetic 
acid (≥99.5 %, TFA), and chitosan (with >75 % deacety-
lation, #417963), were purchased from Sigma-Aldrich 
(Sigma, St. Louis, MI, USA). With the following materials 
purchased elsewhere: HEPES and FCS (PAA, Pasching, 
Austria), SYBR Green Supermix (Bio-Rad), RevertAid H 
Minus M-MulV reverse transcriptase (MBI Fermentas, 
St. Leon-Roth, Germany), TRIzol reagent (Invitrogen), 
CCL2, TNF-α and IL-6 ELISA kits (PeproTech), IL-1-β 
ELISA (R&D Systems), caspase-1 inhibitor Ac-YVAD-
CMK (Calbiochem), epon (Agar Scientific), osmium 
tetroxide (Electron Microscopy Sciences, Hatfield, UK), 
triethylammonium bicarbonate buffer (TEAB) (Fluka, 
Buchs, Switzerland). While trypsin, the LDH detection 
kit CytoTox 96® Non-Radioactive Cytotoxicity Assay, and 
the CellTiterBlue® (CTB) Cell Viability Assay were pur-
chased from Promega (Madison, WI, USA).
Gold nanoparticle synthesis and characterisation
Negatively and positively charged AuNPs were synthe-
sised with adaptions of methods described by Turkevich 
et al. [94] and Jana et al. [95], respectively. Synthesis and 
characterisation have previously been described [89, 96], 
and included size determination using TEM (JEOL 1010 
electron microscope, Japan) and surface charge by zeta 
potential measurements using a Malvern ZetaSizer Nano 
ZS (Malvern Instruments, Malvern, UK).
THP‑1 cell culture
Cells were purchased from the European Collection of 
Cell Cultures (ECACC), and maintained at 2–8  ×  105 
cells/ml under sterile conditions at 37  °C and 5  % CO2, 
using RPMI 1640 general culture medium, supplemented 
with 2 mM l-glutamine, 100 μg/ml streptomycin, 100 IU/
ml penicillin, 10 mM HEPES, and 10 % FCS. Cells were 
maintained for no longer than 20 passages, and were 
seeded for particle exposures at a density of 1.6 × 105 
cells/cm2, to remain within the supplier recommended 
conditions. THP-1 cells were used either in their normal 
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monocyte phenotype, or primed using PMA to allow a 
morphology and behaviour closer to that of macrophage-
like cells. This transition was monitored by observation 
only, with cells becoming adherent and spread, opposed 
to the rounded, suspended monocytes. Co-stimula-
tion with LPS was used to mimic the response of mac-
rophages already undergoing inflammatory responses.
Uptake and trafficking
For TEM, THP-1 cells were treated with an adminis-
tered concentration of 3.2 µg/ml for Au_SC and 2.5 µg/
ml for Au_CHIT for either 30 min or 6 h. To ensure the 
exposure medium remained at physiological pH the 
AuNP stock solutions needed a ten-fold dilution in CCM. 
Therefore, the highest concentrations used here (and 
those of the following experiments) were based on this 
necessity. Cells were then fixed with 1 % glutaraldehyde 
(50  mM) and subsequently washed using 0.05  M caco-
dylate buffer (pH7.2). Post-fixation was performed with 
2 % osmium tetroxide (OsO4) in cacodylate buffer over-
night at 4 °C. After washing with cold water, sample dehy-
dration was performed at 4 °C with sequential increases 
of ethanol concentrations, starting at 10 %. When an eth-
anol concentration of 70 % was reached incubation with 
1  % uranyl acetate in 70  % ethanol was included before 
continuation of ethanol dehydration up until 100 % etha-
nol. After dehydration, cells were embedded using the 
following solutions: a 1:1 (by volume) ethanol:propylene 
oxide mix, followed by propylene oxide alone, and finally 
a 1:1 (by volume) propylene oxide:epon (a low viscos-
ity epoxy resin) mix. TEM micrographs were obtained 
of ultrathin sections (approx. 70  nm) of embedded cell 
suspensions. Cell structural assessment and determina-
tion of AuNP uptake and intracellular trafficking were 
investigated in a LEO 912 AB Omega transmission elec-
tron microscope (Zeiss, Oberkochen) operated at 80 kV 
with a LaB6 cathode. Micrographs were taken in conven-
tional TEM mode. EELS of AuNPs was performed with 
ultrathin sections of embedded cell suspensions (approx. 
40 nm) and analysed at 120 kV, using a magnification of 
31,500 times, a spectrum magnification of 125 times, 
an illumination angle of 3.15 mrad, and exposure time 
of 50  s. Spectra and TEM micrographs were captured 
using a dual speed CCD Slow Scan Camera TRS Sharp-
eye (Troendle, Moorenwies, Germany) and processed in 
iTEM Olympus Software (Münster, Germany).
THP‑1 processing for determination of inflammatory 
responses
Different cell activation states were initially investigated 
for pro-inflammatory mediator release induced by 2.5 µg/
ml Au_CHIT-H. Cells were pre-stimulated with 500 nM 
PMA 24  h prior to experiments, or left un-stimulated. 
This was followed by treatment of Au_CHIT-H for 4 and 
24  h in the presence or absence of 1  ng/ml Escherichia 
coli-derived LPS. Treatments of medium only and LPS 
at 1 ng/ml served as negative controls, while or 100 ng/
ml LPS was used as a positive control. Supernatants 
were assayed for IL-1β by ELISA. PMA priming and LPS 
co-stimulation were chosen to investigate further pro-
inflammatory mediators using all AuNPs described in 
this study. THP-1 cells were treated with Au_SC at 0.2–
3.2 µg/ml and Au_CHIT at 0.2–2.5 µg/ml for 4 and 24 h. 
Supernatants were assayed for CCL2, IL-1β, TNF-α and 
IL-6 by ELISA. The same controls were used as described 
above.
The impact of AuNPs on the complex mechanism of 
IL-1β secretion was further investigated. One h prior to 
AuNP exposure, PMA pre-stimulated THP-1 cells were 
incubated with 100  μM of the caspase-1 inhibitor Ac-
YVAD-CMK for 1 h in serum-free medium, to inhibit the 
activation of the NLRP3 inflammasome. Then in medium 
containing FCS, cells were treated with all AuNPs (Au_
SC at 3.2  µg/ml and Au_CHIT at 2.5  µg/ml) for 4 and 
24 h in the presence or absence of 1 ng/ml LPS. Superna-
tants assayed for TNF-α and IL-1β by ELISA. The same 
controls were used as described above.
Determination of cyto‑/chemokine release
ELISA was performed for each protein with an adap-
tion of the manufacturer’s instructions. Briefly, the cap-
ture antibody, reconstituted in PBS, was added to wells 
of a 96 well plate at 0.25 (CCL2), 1 (TNF-α and IL-6) or 
4 (IL-1-β) µg/ml, and left at 4 °C overnight. Subsequently, 
plates were kept at room temperature. Wells were then 
washed 3 times with wash buffer (0.05  % Tween20 in 
PBS) before addition of blocking buffer (1 % BSA in PBS) 
for 1 h. Following another wash step, standards, at 0-1000 
(CCL2), 0-2000 (TNF-α and IL-6) or 0-250 (IL-1-β) pg/
ml, and samples were added for 2  h, with subsequent 
wash step. Detection antibody, diluted to 500 (CCL2, 
TNF-α and IL-6) or 200 (IL-1-β) ng/ml in assay diluent 
(0.05 % Tween-20 and 0.1 % BSA in PBS), was added for 
2  h, and plates were subsequently washed. An avidin-
HRP conjugate was added for 30 min. A final wash step 
was performed, followed by the addition of a TMB sub-
strate. After the reaction was stopped, using 2 M H2SO4, 
the plates were measured on a plate reader (Infinity 200 
Pro, Tecan, Groedig, Austria) at 450 nm with a reference 
wavelength of 650 nm, and protein concentrations deter-
mined with use of protein standard curves.
Determination of inflammasome activation
For determination of IL-1β and NLRP3 gene expression 
induced by AuNPs total RNA was isolated from cells using 
TRIzol reagent and cDNA was generated with RevertAid 
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H Minus M-MulV reverse transcriptase, following the 
manufacturer’s instructions. Quantitative real-time RT-
PCR (qRT-PCR) was performed using a Rotorgene 3000 
(Corbett Research, Mortlake, Australia), with iQ SYBR 
Green Supermix and the following primers: human IL-1β 
sense, 5′-GTACCTGAGCTCGCCAGTGA-3′,and anti-
sense, 5′-TCGGAGATTCGTAGCTGGATG-3′; human 
NLRP3 sense, 5′-TCAGCACTAATCAGAATCTCACG-
CACCTTT-3′, and antisense, 5′-CCAGGTCATT-
GTTGCCCAGGCTC-3′; and human RPLP0 sense, 
5′-GGCACCATTGAAATCCTGAGTGATGTG-3′, and 
antisense, 5′-TTGCGGACACCCTCCAGGAAG-3′. The 
large ribosomal protein P0 (RPLP0) was used as a refer-
ence gene, and PCR specificity was confirmed through 
assessment of the PCR product melting curves. Quanti-
fication of relative mRNA expression levels were calcu-
lated in relation to the RPLP0 housekeeping gene using 
the delta delta method of Pfaffl [97].
Cytotoxicity and cell viability
After AuNP exposures, supernatants were collected 
for determination of released LDH. Fresh medium was 
added to wells and cell viability was then determined 
using the CellTiterBlue® (CTB) Cell Viability Assay. CTB 
reagent was added at a ratio of 1:5 and cells were place at 
37  °C for 60  min, after which the fluorescence intensity 
was measured at ex560/em590 on a plate reader (Infin-
ity 200 Pro, Tecan, Groedig, Austria). LDH was deter-
mined in a colorimetric reaction using the CytoTox 96® 
Non-Radioactive Cytotoxicity Assay. After collection, the 
supernatants were centrifuged for 10 min at 25000g, 30 µl 
was transferred to transparent 96-well plates, followed 
by 30  µl assay substrate. Plates were then incubated at 
room temperature for 20 min prior to addition of 30 µl 
stop solution, followed by absorbance measurements at 
490 nm using a plate reader.
Protein corona analysis
For protein binding experiments, three concentrations 
were used; 10 % FCS, as used in standard in vitro CCM, 
55  % FCS, as this is the plasma percentage within whole 
blood, and 100  % FCS as a control for full protein con-
tent. AuNPs were incubated in the presence of FCS for 
24  h and subsequently washed three times and isolated 
via centrifugation. The number and identity of proteins 
present, associated with NPs or NP agglomerates, were 
characterised via LTQ-Orbitrap mass spectrometry (MS). 
Each sample was dissolved in 50 µl 0.5  mol/l TEAB, fol-
lowed by denaturation at 60  °C for 30  min. Protein con-
centrations were then determined by the Bradford assay. 
Disulfide bonds were reduced by adding 4.5 µl of a 50 mM 
TCEP-HCl, followed by 1 h incubation at 60 °C. The sam-
ples were alkylated by adding 8.7 mM IAA for 30 min at 
RT, protected from light. Tryptic digestion was performed 
overnight at 37 °C, using trypsin at a ratio of 1:50 in rela-
tion to protein concentration. The following day samples 
were purified with C18 Tips (according to the manufactur-
er’s instructions, Thermo Fisher Scientific, Bremen, Ger-
many) to remove NPs and salts. After which, each sample 
was adjusted to a concentration of 1 µg/µl through drying 
and dissolving in mobile phase A (ultrapure water with 
0.050  % TFA). The sample constituents were separated 
by nano-ion-pair reversed-phase—HPLC (U3000 nano, 
Dionex, Germany) at pH 2 and detected by LTQ-Orbitrap-
MS (LTQ Orbitrap XL, Thermo Fisher Scientific, equipped 
with a nano-electrospray ionization source). The flow rate 
was set to 1 µl/min and a poly-styrene/divinylbenzene (PS-
DVB) monolithic 150  ×  0.2  mm I.D. column (produced 
in-house according to Premstaller et  al. [98]) was used 
for separation. A 2 h gradient of 0–40 % ACN in 0.050 % 
TFA at 55 °C was applied. To identify peptides, three data-
dependent collision-induced dissociation (CID) scans 
were performed. The MS1 survey scans of the eluting pep-
tides were executed in the Orbitrap with a resolution of 
60,000, recording a window between m/z 450 and 2000. To 
identify peptides, three data-dependent collision-induced 
dissociation (CID) scans of the precursor ions were car-
ried out in the ion trap. The normalised collision energy 
(NCE) was set at 35 % for all CID scans. The FCS samples 
were measured three times with the use of exclusion lists. 
This procedure facilitated the identification of more pro-
teins compared to using a single measurement. The data 
were analysed with Proteome Discoverer™ (Thermo Fisher 
Scientific, Version 1.3). Following parameters for the Spec-
trum Selector node were set: min. precursor mass 350 Da; 
max. precursor mass 5000  Da; s/n threshold 1.5. Param-
eters for Mascot (in-house server: version 2.3.2.) searches 
were as follows: precursor mass tolerance 10  ppm; frag-
ment mass tolerance 0.5  Da; Trypsin; 1 missed cleavage 
site; Uniprot (taxonomy: mammalia) knowledgebase; 
dynamic modifications: oxidation (M) and deamidation 
(NQ); fixed modification: carbamidomethylation (C). The 
Peptide Validator tool was used for the processing node 
and the target false discovery rate (FRD) value was set to 
0.01 (strict) and 0.05 (relaxed). Proteins were further char-
acterised by their biological function, isoelectric point (pI), 
molecular weight (MW), hydropathicity (GRAVY) and 
aliphatic index, using the ProtParam tool and the UniProt 
knowledgebase of http://www.expasy.org. The data col-
lected for the AuNP interactions with FCS proteins were 
obtained with three independent biological replicates and 
three technical replicates of each biological replicate.
Statistical analysis
Statistical analysis of data was performed using PASW 
statistics 18 (SPSS, IBM), and treatments were considered 
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statistically significant when p  <  0.05. Differences 
between exposures of AuNPs and those of relevant con-
trols (medium only, or 1 ng/ml LPS) were determined by 
ANOVA, with post hoc Tukey comparisons for pairwise 
analysis. Specific comparisons (i.e. treatments with and 
without caspase-1 inhibition) were made using an Inde-
pendent Samples T Test. Relationships between AuNP 
dose and cytokine secretion were further assessed using 
the Spearman rank-order correlation coefficient.
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Additional files
Additional file 1. EELS measured at sites of electron dense particulate 
matter observed in micrographs. Intracellular particles are identified with 
red lines (A–F), extracellular particles with green lines (E–F), and particles 
observed during perceived exocytosis with red lines (G–H); Au = gold, 
Co = control, P = phosphorus.
Additional file 2. Au_CHIT‑L induced cytotoxicity in THP‑1 cells. Viability 
(mitochondrial activity) (A) and cytotoxicity (LDH release) (B) in PMA‑
stimulated cells, after treatment with Au_CHIT‑L, for 24 and 48 h; 1 ng/
ml LPS was used for co‑stimulation, Triton X‑100 was used as positive 
control. Results are expressed as, for viability,  % viability compared to 
100 % control cells, and as the ratio change compared to controls for LDH 
release, and each data point represents the mean ± SEM, R = 4; statistical 
significance (determined by ANOVA with Tukey posthoc) is shown by 
^ = p < 0.05 for 24 h, and * = p < 0.05 for 48 h, compared to relevant 
controls.
Additional file 3. Cytotoxicity assessment of NP solvents in THP‑1 cells. 
Viability (mitochondrial activity) (A‑C) and cytotoxicity (LDH release) (D‑F) 
in PMA‑stimulated cells, after treatment with sodium citrate (2.2 mM 
stock) or chitosan (0.1 % stock) at dilutions relevant to AuNP exposures, for 
4, 24 and 48 h; 1 ng/ml LPS was used for co‑stimulation, Triton X‑100 was 
used as positive control. Results are expressed as fluorescence intensity for 
viability assays, and as absorbance for LDH release, R = 3, each data point 
represents the mean ± SEM.
Additional file 4. AuNPs induced pro‑inflammatory response of THP‑1 
cells in different cell activation states. IL‑1β release from THP‑1 cells in 
response to treatment with Au_CHIT‑H (administered dose of 2.5 µg/ml) 
for 4 (A and C) or 24 h (B and D), in the presence and absence of 1 ng/
ml LPS co‑stimulation, and without (A‑B) or with (C‑D) PMA‑priming. 
Results are expressed as IL‑1β release (pg/ml), and each data point 
represents the mean ± SEM, R = 3. Statistical significance is shown by 
* = p < 0.05, ** = p < 0.01 and *** = p < 0.005, compared to relevant 
controls (medium only or 1 ng/ml LPS); 100 ng/ml LPS was used as posi‑
tive control.
Additional file 5. Immune response of THP‑1 cells to NP solvents. 
Secretion of CCL2 (A‑C), TNF‑α (D‑F), IL‑6 (G‑I) and IL‑1ß (J‑L) from PMA‑
stimulated cells, in response to sodium citrate (2.2 mM stock) or chitosan 
(0.1 % stock) at dilutions relevant to AuNP exposures; 1 ng/ml LPS was 
used for co‑stimulation; with 1 and 100 ng/ml LPS for controls; results 
are expressed as cytokine release in pg/ml, R = 3, and each data point 
represents the mean ± SEM.
Additional file 6. Proteins bound to AuNP when using 10 % FCS. The 
identity of unique proteins identified, via LTQ‑Orbitrap mass spec‑
trometry, in AuNP‑FCS complexes were identified using http://www.
uniprot.org (taxonomy: mammalia); evaluated when incubated in 10 % 
FCS; data presented is of unique proteins identified in all 3 biological 
replicates; this analysis was performed with 3 technical replicates of 
each biological replicate; for confidence of identification the proteins 
presented in these graphs are only proteins found in every biological 
replicate.
Additional file 7. Proteins bound to AuNP when using 55 % FCS. The 
identity of unique proteins identified, via LTQ‑Orbitrap mass spectrom‑
etry, in AuNP‑FCS complexes were identified using http://www.uniprot.
org (taxonomy: mammalia); evaluated when incubated in 55 % FCS; data 
presented is of unique proteins identified in all 3 biological replicates; 
this analysis was performed with 3 technical replicates of each biological 
replicate; for confidence of identification the proteins presented in these 
graphs are only proteins found in every biological replicate.
Additional file 8. Proteins bound to AuNP when using 100 % FCS. The 
identity of unique proteins identified, via LTQ‑Orbitrap mass spectrometry, 
in AuNP‑FCS complexes were identified using http://www.uniprot.org 
(taxonomy: mammalia); evaluated when incubated in 100 % FCS; data 
presented is of unique proteins identified in all 3 biological replicates; 
this analysis was performed with 3 technical replicates of each biological 
replicate; for confidence of identification the proteins presented in these 
graphs are only proteins found in every biological replicate.
Additional file 9. General pattern of AuNP‑protein interactions – number 
of unique proteins. The number of unique proteins identified, via LTQ‑
Orbitrap mass spectrometry, in AuNP‑FCS complexes were identified 
using http://www.uniprot.orf (taxonomy: mammalia); evaluated when 
incubated in 10, 55, and 100 % FCS; data presented is of unique proteins 
identified in every biological replicate and all 3 serum conditions.
Additional file 10. General pattern of AuNP‑protein interactions – 
identity of unique proteins. The identity of unique proteins identified, via 
LTQ‑Orbitrap mass spectrometry, in AuNP‑FCS complexes were identified 
using http://www.uniprot.org (taxonomy: mammalia); evaluated when 
incubated in 10, 55, and 100 % FCS; data presented is of unique proteins 
identified in every biological replicate and all 3 serum conditions.
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